Cardiovascular Systems Sees Peripheral OAS Micro Crown Success
Zacks Investment Research | Dec 16, 2019 08:22PM ET
Cardiovascular Systems, Inc. (NASDAQ:CSII) has successfully treated the first patient in Europe with its Stealth 360 Peripheral Orbital Atherectomy System (OAS) 1.25 mm Micro Crown with GlideAssist (1.25 Micro Crown). The company has launched the 1.25 Micro Crown in Germany, in partnership with OrbusNeich, a leading provider of cardiovascular solutions.
This is a major achievement for the company toward strengthening its portfolio for the treatment of critical limb ischemia or CLI.
More About the 1.25 Micro Crown
The 1.25 Micro Crown is a minimally-invasive option to efficiently treat CLI by modifying calcified lesions below the knee and resuming blood flow to the foot.
The GlideAssist feature aids the 1.25 Micro Crown to rotate at a tedious speed of 5K rpm, thereby ensuring easier tracking and movement needed to access diffuse, calcified lesions located below the knee. The device’s dual mechanism of action of differential sanding and pulsatile forces will be critical in treating the challenging calcified lesions found below the knee.
Market Prospects
Per Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.